Skip to Main Content
Welcome to theĀ Scientist.comĀ Marketplace

Go to Main Navigation

BP7576a

LGALS1 Antibody Blocking Peptide

Abcepta

DETAILS

  • Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
  • Gene Id: 3956
  • Category: Peptides; Blocking Peptides
  • Subtitle: Synthetic peptide
  • Gene Name: LGALS1
  • Other Names: Galectin-1, Gal-1, 14 kDa laminin-binding protein, HLBP14, 14 kDa lectin, Beta-galactoside-binding lectin L-14-I, Galaptin, HBL, HPL, Lactose-binding lectin 1, Lectin galactoside-binding soluble 1, Putative MAPK-activating protein PM12, S-Lac lectin 1, LGALS1
  • Availability: 2 weeks
  • Bio Background: The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS1 may act as an autocrine negative growth factor that regulates cell proliferation.
  • Bio References: Bi,S.,J. Biol. Chem. 283 (18), 12248-12258 (2008)Le Mercier,M., J. Neuropathol. Exp. Neurol. 67 (5), 456-469 (2008)Pacienza,N., FASEB J. 22 (4), 1113-1123 (2008)
  • Primary Accession: P09382
  • Targetspecificity: The synthetic peptide sequence used to generate the antibody AP7576a was selected from the region of human LGALS1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.